Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Athena Diagnostics | RCV000518446 | SCV000613984 | uncertain significance | not specified | 2016-11-21 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000689949 | SCV000817621 | likely benign | LAMA2-related muscular dystrophy | 2024-11-24 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002527492 | SCV003532333 | likely benign | Inborn genetic diseases | 2021-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Revvity Omics, |
RCV003129880 | SCV003814060 | uncertain significance | not provided | 2021-06-16 | criteria provided, single submitter | clinical testing | |
| Mayo Clinic Laboratories, |
RCV003129880 | SCV004223938 | uncertain significance | not provided | 2023-06-22 | criteria provided, single submitter | clinical testing | BP4 |
| Gene |
RCV003129880 | SCV005080719 | uncertain significance | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31983221) |